AI-Designed Intrabodies Target Brain Diseases

Researchers developed an AI method to create tiny disease-fighting molecules that work within human cells ^[1]. These "intrabodies" target neurodegenerative disorders such as Alzheimer's, Parkinson's, and motor neuron disease (MND) ^[1]. This technique offers a potential new path for treating conditions that affect the brain ^[1].

The AI system helps design molecules to neutralize harmful protein buildup directly inside neurons ^[1]. This cellular approach may solve challenges faced by traditional drug delivery methods ^[1]. Scientists hope this advancement will accelerate the creation of effective neurodegenerative therapies ^[1].